2.88
0.37 (14.74%)
| Previous Close | 2.51 |
| Open | 2.52 |
| Volume | 3,437,780 |
| Avg. Volume (3M) | 3,307,425 |
| Market Cap | 321,518,432 |
| Price / Earnings (Forward) | 12.50 |
| Price / Sales | 0.140 |
| Price / Book | 0.600 |
| 52 Weeks Range | |
| Earnings Date | 7 May 2026 |
| Profit Margin | -4.54% |
| Operating Margin (TTM) | 0.35% |
| Diluted EPS (TTM) | -1.23 |
| Quarterly Revenue Growth (YOY) | -24.40% |
| Total Debt/Equity (MRQ) | 77.09% |
| Current Ratio (MRQ) | 0.990 |
| Operating Cash Flow (TTM) | 18.42 M |
| Levered Free Cash Flow (TTM) | 2.23 M |
| Return on Assets (TTM) | -0.04% |
| Return on Equity (TTM) | -9.24% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Bearish | Mixed |
| Health Information Services (Global) | Bearish | Mixed | |
| Stock | Evolent Health, Inc | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | 1.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 5.0 |
| Technical Oscillators | -2.0 |
| Average | 1.13 |
|
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Value |
| % Held by Insiders | 1.55% |
| % Held by Institutions | 108.63% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Cadian Capital Management, Lp | 31 Dec 2025 | 11,085,455 |
| Rubicon Founders Llc | 31 Dec 2025 | 5,816,123 |
| Rock Springs Capital Management Lp | 31 Dec 2025 | 2,675,000 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 8.00 (BTIG, 177.78%) | Buy |
| Median | 5.00 (73.61%) | |
| Low | 3.00 (RBC Capital, 4.17%) | Hold |
| Average | 5.14 (78.47%) | |
| Total | 6 Buy, 1 Hold | |
| Avg. Price @ Call | 3.28 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Oppenheimer | 02 Mar 2026 | 6.00 (108.33%) | Buy | 3.58 |
| Citigroup | 26 Feb 2026 | 4.00 (38.89%) | Buy | 3.32 |
| Truist Securities | 26 Feb 2026 | 6.00 (108.33%) | Buy | 3.32 |
| UBS | 26 Feb 2026 | 5.00 (73.61%) | Buy | 3.32 |
| BTIG | 25 Feb 2026 | 8.00 (177.78%) | Buy | 3.14 |
| 02 Feb 2026 | 10.00 (247.22%) | Buy | 3.26 | |
| Needham | 25 Feb 2026 | 4.00 (38.89%) | Buy | 3.14 |
| RBC Capital | 25 Feb 2026 | 3.00 (4.17%) | Hold | 3.14 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 04 Feb 2026 | Announcement | Evolent To Release 2025 Fourth Quarter and Year-End Financial Results on Tuesday, February 24, 2026 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |